# A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy

> **NCT03331640** · PHASE2 · TERMINATED · sponsor: **AIO-Studien-gGmbH** · enrollment: 67 (actual)

## Conditions studied

- Metastatic Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** OFF
- **DRUG:** FOLFIRI Protocol

## Key facts

- **NCT ID:** NCT03331640
- **Lead sponsor:** AIO-Studien-gGmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-01-02
- **Primary completion:** 2021-09-13
- **Final completion:** 2021-09-13
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** slow recruitment
- **Last updated:** 2022-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03331640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03331640, "A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03331640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*